Philip D. Acott

796 total citations
35 papers, 433 citations indexed

About

Philip D. Acott is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Philip D. Acott has authored 35 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 7 papers in Molecular Biology. Recurrent topics in Philip D. Acott's work include Renal Transplantation Outcomes and Treatments (5 papers), Polyomavirus and related diseases (4 papers) and Full-Duplex Wireless Communications (4 papers). Philip D. Acott is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Polyomavirus and related diseases (4 papers) and Full-Duplex Wireless Communications (4 papers). Philip D. Acott collaborates with scholars based in Canada, Switzerland and Germany. Philip D. Acott's co-authors include John F. S. Crocker, Hans H. Hirsch, Joseph Lawen, H Bitter-Suermann, Bianca Lang, Kenneth W. Renton, Christopher J. Sinal, Albert D. Fraser, David Worth and Kerry B. Goralski and has published in prestigious journals such as American Journal of Kidney Diseases, Transplantation and Clinical Pharmacology & Therapeutics.

In The Last Decade

Philip D. Acott

35 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip D. Acott Canada 13 167 87 79 62 60 35 433
Kalyanasundaram Venkataraman United States 13 138 0.8× 156 1.8× 85 1.1× 85 1.4× 83 1.4× 29 693
L Mieles United States 15 53 0.3× 62 0.7× 72 0.9× 23 0.4× 24 0.4× 22 586
John Dunn United States 7 97 0.6× 161 1.9× 48 0.6× 103 1.7× 31 0.5× 14 617
Craig W. Freyer United States 12 199 1.2× 14 0.2× 110 1.4× 31 0.5× 56 0.9× 47 524
Luigi Porcaro Italy 12 77 0.5× 21 0.2× 96 1.2× 146 2.4× 26 0.4× 22 450
J. Fryer United States 10 46 0.3× 42 0.5× 62 0.8× 154 2.5× 34 0.6× 12 796
Kristien J. Ledeganck Belgium 14 53 0.3× 45 0.5× 186 2.4× 73 1.2× 75 1.3× 34 830
J McKiernan Ireland 12 54 0.3× 82 0.9× 88 1.1× 75 1.2× 50 0.8× 34 472
Fenghua Peng China 12 60 0.4× 16 0.2× 155 2.0× 56 0.9× 28 0.5× 49 474
Amel Chaabane Tunisia 13 44 0.3× 87 1.0× 37 0.5× 24 0.4× 9 0.1× 72 504

Countries citing papers authored by Philip D. Acott

Since Specialization
Citations

This map shows the geographic impact of Philip D. Acott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Acott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Acott more than expected).

Fields of papers citing papers by Philip D. Acott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Acott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Acott. The network helps show where Philip D. Acott may publish in the future.

Co-authorship network of co-authors of Philip D. Acott

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Acott. A scholar is included among the top collaborators of Philip D. Acott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Acott. Philip D. Acott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arts, Heleen H., et al.. (2022). Increased intracranial pressure in a patient with Congenital Heart Defect and Ectodermal Dysplasia (CHDED): Extension of phenotype and review of literature. American Journal of Medical Genetics Part A. 191(2). 554–558. 2 indexed citations
2.
Trites, Jonathan, et al.. (2021). Oral Losartan After Limited Mandibulectomy for Treatment of Desmoid-Type Fibromatosis. Ear Nose & Throat Journal. 102(2). NP49–NP52. 6 indexed citations
3.
Oviedo, Angélica, Erik K. Mont, & Philip D. Acott. (2017). Radiology and Pathology in a Child With Calcification and Simplified Gyration. Pediatric Neurology. 78. 80–81. 1 indexed citations
4.
Lehman, Anna, et al.. (2017). Hypogonadotropic Hypogonadism in Males with Glycogen Storage Disease Type 1. JIMD Reports. 36. 79–84. 4 indexed citations
5.
LeBlanc, Marissa A., Lynette S. Penney, Daniel Gaston, et al.. (2013). A novel rearrangement of occludin causes brain calcification and renal dysfunction. Human Genetics. 132(11). 1223–1234. 22 indexed citations
6.
Seamone, Mark E., Wenjie Wang, Philip D. Acott, et al.. (2010). MAP kinase activation increases BK polyomavirus replication and facilitates viral propagation in vitro. Journal of Virological Methods. 170(1-2). 21–29. 14 indexed citations
7.
Acott, Philip D., et al.. (2008). Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells. Transplant International. 22(2). 225–231. 18 indexed citations
8.
Acott, Philip D. & Hans H. Hirsch. (2007). BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatric Nephrology. 22(9). 1243–1250. 44 indexed citations
9.
Crocker, John F. S., et al.. (2007). An Acadian variant of Fanconi syndrome. Pediatric Nephrology. 22(10). 1711–1715. 4 indexed citations
10.
Acott, Philip D.. (2006). Home fingerprick sampling for immunosuppressant drug monitoring in pediatric renal transplant patients. Nature Clinical Practice Nephrology. 2(6). 304–305. 7 indexed citations
11.
Dyack, Sarah, et al.. (2006). Fabry disease and nephrogenic diabetes insipidus. Pediatric Nephrology. 21(8). 1185–1188. 7 indexed citations
12.
Acott, Philip D., et al.. (2006). Pamidronate distribution in pediatric renal and rheumatologic patients. European Journal of Clinical Pharmacology. 62(12). 1013–1019. 1 indexed citations
13.
Acott, Philip D.. (2006). Polyoma virus in pediatric renal transplantation. Pediatric Transplantation. 10(7). 856–860. 8 indexed citations
14.
Acott, Philip D., et al.. (2005). Pamidronate treatment of pediatric fracture patients on chronic steroid therapy. Pediatric Nephrology. 20(3). 368–373. 43 indexed citations
15.
Tee, James B., et al.. (2004). Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: a single-center, 20-year review. American Journal of Kidney Diseases. 43(2). 296–303. 21 indexed citations
16.
Renton, Kenneth W., et al.. (2003). Determination of pamidronate in human whole blood and urine by reversed‐phase HPLC with fluorescence detection. Biomedical Chromatography. 18(2). 98–101. 30 indexed citations
17.
Resch, Lothar, Weiming Yu, Robert B. Fraser, et al.. (2002). T-cell/periodic acid-schiff stain: A useful tool in the evaluation of tubulointerstitial infiltrates as a component of renal allograft rejection. Annals of Diagnostic Pathology. 6(2). 122–124. 1 indexed citations
18.
Acott, Philip D., et al.. (2001). Extravesical ureteroneocystostomy with and without internalized ureteric stents in pediatric renal transplantation. Pediatric Transplantation. 5(1). 21–26. 49 indexed citations
19.
Acott, Philip D., Spencer H. S. Lee, H Bitter-Suermann, Joseph Lawen, & John F. S. Crocker. (1996). INFECTION CONCOMITANT WITH PEDIATRIC RENAL ALLOGRAFT REJECTION. Transplantation. 62(5). 689–691. 22 indexed citations
20.
McLellan, Roman A., et al.. (1995). Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation*. Clinical Pharmacology & Therapeutics. 58(3). 322–327. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kalyanasundaram Venkataraman Breakdown of academic impact, for papers by L Mieles Breakdown of academic impact, for papers by John Dunn Breakdown of academic impact, for papers by Craig W. Freyer Breakdown of academic impact, for papers by Luigi Porcaro Breakdown of academic impact, for papers by J. Fryer Breakdown of academic impact, for papers by Kristien J. Ledeganck Breakdown of academic impact, for papers by J McKiernan Breakdown of academic impact, for papers by Fenghua Peng Breakdown of academic impact, for papers by Amel Chaabane
Rankless by CCL
2026